Kaihua Lu - Publications

Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for driver gene-negative advanced NSCLC: a single-center retrospective real-world study.

Journal: Frontiers in oncology

Published: October 03, 2025

Identification of mitochondrial-related genes to evaluate the immune infiltration and prognosis of lung adenocarcinoma.

Journal: PeerJ

Published: April 23, 2025

First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: January 12, 2025

First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial.

Journal: Nature medicine

Published: August 16, 2024

Poor therapeutic outcomes in KRAS-mutant non-small cell lung cancer due to chemoresistance conferred by SLC7A11.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 04, 2024

Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2024

Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.

Journal: Frontiers in oncology

Published: May 30, 2024

A retrospective analysis of immunotherapy in non-small cell lung cancer patients with targetable genetic mutations.

Journal: Medicine

Published: April 18, 2024

TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer.

Journal: Immunology

Published: October 11, 2023

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study.

Journal: Frontiers in oncology

Published: June 27, 2023

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review.

Journal: Current oncology (Toronto, Ont.)

Published: April 25, 2023

Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).

Journal: Translational lung cancer research

Published: January 19, 2023